Safety and Efficacy of CC-10004 for Prurigo Nodularis
NCT00869089
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Prurigo Nodularis
Interventions
DRUG:
CC-10004
Sponsor
University Hospitals Cleveland Medical Center
Collaborators
[object Object]